By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – UK biomarker discovery firm Abcodia announced today it has secured £1 million ($1.4 million) in funding.

The funding comes from Albion Ventures and UCL Business. Abcodia will use the investment to conduct translational studies using its longitudinal serum collection licensed from University College London.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.